NCT02746328 2024-02-26Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body MassGTxPhase 2 Withdrawn
NCT02463032 2020-12-09Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast CancerGTxPhase 2 Completed136 enrolled 14 charts